Gene Therapy: The ‘pro-sense’ approach to Duchenne muscular dystrophy

This publication has 7 references indexed in Scilit:

• Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
  Proceedings of the National Academy of Sciences, 2004
• Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping
  Science, 2004
• Advances in Duchenne muscular dystrophy gene therapy
  Nature Reviews Genetics, 2003
• Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
  Nature Medicine, 2003
• Massive Idiosyncratic Exon Skipping Corrects the Nonsense Mutation in Dystrophic Mouse Muscle and Produces Functional Revertant Fibers by Clonal Expansion
  The Journal of cell biology, 2000
• Double-Target Antisense U7 snRNAs Promote Efficient Skipping of an Aberrant Exon in Three Human -Thalassemic Mutations
  Human Molecular Genetics, 1999
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
  Genomics, 1988